α-synuclein genetic variability: A biomarker for dementia in Parkinson disease
- PMID: 27091628
- DOI: 10.1002/ana.24664
α-synuclein genetic variability: A biomarker for dementia in Parkinson disease
Abstract
Objective: The relationship between Parkinson disease (PD), PD with dementia (PDD), and dementia with Lewy bodies (DLB) has long been debated. Although PD is primarily considered a motor disorder, cognitive impairment is often present at diagnosis, and only ∼20% of patients remain cognitively intact in the long term. Alpha-synuclein (SNCA) was first implicated in the pathogenesis of the disease when point mutations and locus multiplications were identified in familial parkinsonism with dementia. In worldwide populations, SNCA genetic variability remains the most reproducible risk factor for idiopathic PD. However, few investigators have looked at SNCA variability in terms of cognitive outcomes.
Methods: We have used targeted high-throughput sequencing to characterize the 135kb SNCA locus in a large multinational cohort of patients with PD, PDD, and DLB and healthy controls.
Results: An analysis of 43 tagging single nucleotide polymorphisms across the SNCA locus shows 2 distinct association profiles for symptoms of parkinsonism and/or dementia, respectively, toward the 3' or the 5' of the SNCA gene. In addition, we define a specific haplotype in intron 4 that is directly associated with PDD. The PDD risk haplotype has been interrogated at single nucleotide resolution and is uniquely tagged by an expanded TTTCn repeat.
Interpretation: Our data show that PD, PDD, and DLB, rather than a disease continuum, have distinct genetic etiologies albeit within one genomic locus. Such results may serve as prognostic biomarkers to these disorders, to inform physicians and patients, and to assist in the design and stratification of clinical trials aimed at disease modification. Ann Neurol 2016;79:991-999.
© 2016 American Neurological Association.
Similar articles
-
Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.Alzheimers Dement. 2017 Nov;13(11):1237-1250. doi: 10.1016/j.jalz.2017.03.001. Epub 2017 Apr 18. Alzheimers Dement. 2017. PMID: 28431219 Free PMC article.
-
Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies.Ann Neurol. 2020 Apr;87(4):584-598. doi: 10.1002/ana.25687. Epub 2020 Feb 12. Ann Neurol. 2020. PMID: 31976583 Free PMC article.
-
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8. J Neural Transm (Vienna). 2018. PMID: 29222591 Review.
-
Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.Neurosci Lett. 2019 Jul 27;706:146-150. doi: 10.1016/j.neulet.2019.05.026. Epub 2019 May 15. Neurosci Lett. 2019. PMID: 31102707
-
Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies.Parkinsonism Relat Disord. 2010 Jun;16(5):307-15. doi: 10.1016/j.parkreldis.2010.02.015. Epub 2010 Mar 24. Parkinsonism Relat Disord. 2010. PMID: 20338799 Review.
Cited by
-
Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study.Brain Commun. 2022 Mar 15;4(2):fcac040. doi: 10.1093/braincomms/fcac040. eCollection 2022. Brain Commun. 2022. PMID: 35350553 Free PMC article.
-
Cognitive heterogeneity in Parkinson's disease: A mechanistic view.Neuron. 2023 May 17;111(10):1531-1546. doi: 10.1016/j.neuron.2023.03.021. Epub 2023 Apr 6. Neuron. 2023. PMID: 37028431 Free PMC article. Review.
-
Classification of advanced stages of Parkinson's disease: translation into stratified treatments.J Neural Transm (Vienna). 2017 Aug;124(8):1015-1027. doi: 10.1007/s00702-017-1707-x. Epub 2017 Mar 24. J Neural Transm (Vienna). 2017. PMID: 28342083 Free PMC article. Review.
-
Deep Brain Stimulation in Parkinson's Disease: New and Emerging Targets for Refractory Motor and Nonmotor Symptoms.Parkinsons Dis. 2017;2017:5124328. doi: 10.1155/2017/5124328. Epub 2017 Jul 6. Parkinsons Dis. 2017. PMID: 28761773 Free PMC article. Review.
-
Genetics of synucleins in neurodegenerative diseases.Acta Neuropathol. 2021 Apr;141(4):471-490. doi: 10.1007/s00401-020-02202-1. Epub 2020 Aug 1. Acta Neuropathol. 2021. PMID: 32740728 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous